Schizophrenia Clinical Trials
Schizophrenia clinical trials evaluate new treatments, behavioral therapies, and medications for schizophrenia. Corterve compiles actively recruiting Schizophrenia studies from the ClinicalTrials.gov registry so you can search by location and eligibility criteria. Participation is always voluntary and confidential. This information is educational and not medical advice — talk with a licensed clinician about whether a study is right for you.
Recruiting Schizophrenia studies
- A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With SchizophreniaNCT06894212PHASE3Otsuka Pharmaceutical Development & Commercialization, Inc.Bentonville, Arkansas
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsNCT07565428PHASE3Minerva NeurosciencesBellflower, California
- Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With SchizophreniaNCT07467993PHASE2Novartis PharmaceuticalsBentonville, Arkansas
- Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant SchizophreniaNCT07184619PHASE3Newron Pharmaceuticals SPALos Angeles, California
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderNCT06229210PHASE3Intra-Cellular Therapies, Inc.Phoenix, Arizona
- Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaNCT07363577PHASE3LB Pharmaceuticals Inc.Bentonville, Arkansas
- 52-week Open Label Safety-Tolerability StudyNCT07369154PHASE3LB Pharmaceuticals Inc.Chandler, Arizona
- Cognitive Strategies in Early Psychosis 2NCT07263022PHASE3University of MinnesotaMinneapolis, Minnesota
- Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective AccuracyNCT07098169NAUniversity of California, San DiegoSan Diego, California
- Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental IllnessNCT04940663NAMassachusetts General HospitalCharlestown, Massachusetts
- Precision Brain Stimulation to Reduce Cannabis Craving in SchizophreniaNCT07196462NAVanderbilt University Medical CenterNashville, Tennessee
- Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum DisordersNCT07290738NAThe University of Texas Health Science Center, HoustonHouston, Texas
Schizophrenia trials by state
Schizophrenia trials by metro
Frequently asked questions
- How do I find recruiting Schizophrenia clinical trials?
- Corterve aggregates actively recruiting Schizophrenia studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Schizophrenia clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Schizophrenia clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.